Navigation Links
Calls to combat deafness after chemotherapy

The Royal National Institute for Deaf people (RNID) has asked drug companies to find ways of reducing the occurrence of deafness among cancer patients who survive chemotherapy. //

The Institute is looking mainly at the effects of the anti-tumor agent cisplatin, which has been successfully used to combat a variety of cancers in adults as well as children. Cisplatin is a platinum-based chemotherapy, which has successfully cured 30 percent of cancers in children and about 25 percent of adult cancers. But it has a major flaw in that it causes tinnitus or ringing in the ears. RNID commercial research manager, Munna Vio said, "Our research indicates that if a suitable drug was approved that effectively protected against hearing loss, but did not interfere with chemotherapy, oncologists would use it across the board for all cancers treated with cisplatin. Thousands of survivors are being left with unnecessary hearing damage."

Drug companies say that such a drug, which blocks the unwanted effects of chemotherapy, is already available. Penelope Brock, a leading British oncologist has also added her voice to this cause, "Permanent side-effects are the most damaging, and hearing loss is one which affects everyday life and development." She feels that with adequate incentive an otoprotectant drug could be on the market within two years.


'"/>




Page: 1

Related medicine news :

1. WHO Calls For Greater Emphasis On Combating AIDS
2. PCT Calls Upon Doctor To Delay Surgeries
3. UN Calls For More Funds For Earthquake Affected
4. MP Calls For Ban On Aspartame
5. Scientist Calls Upon Media To Retract His Work
6. CMHA Calls For Better Trained Police For Dealing With The Mentally Ill
7. US Government Calls For Better Drug Supplies
8. Report Calls For Better Implementation Of Last Wishes of Terminally Ill
9. Mixed Orientation Marriages Calls for Deeper Understanding
10. Rare Sexual Syndrome In Women Calls For More Research
11. Bihar CM Calls For Concerted Efforts To Tackle HIV/AIDS Menace
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... ... May 23, 2017 , ... Axiad IDS , a leading ... Applications magazine has named the company a “Top 25 Cybersecurity Companies 2017.” ... to help organizations simply and proactively address potential cybersecurity threats before they happen. ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... technology and a 2017 Best in KLAS category winner, has named Daniel P. ... to extend and enhance its technology platform and product offerings,” says Justin Neece, ...
(Date:5/23/2017)... ... May 23, 2017 , ... Drs. ... on peri-implantitis in Las Vegas, NV, and the importance of treating ... disease consultation and leading care for peri-implantitis, with or without a referral. As ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients with symptoms of gum disease ... receive laser gum disease treatments from the doctors at Art of Dentistry, without first ... awareness of the importance of receiving qualified treatment in order to avoid systemic health ...
(Date:5/22/2017)... ... May 22, 2017 , ... Patients who avoid necessary dental and ... dentistry in Mt. Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of ... treatments. One or more sedation methods may be recommended based on the severity of ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
(Date:5/10/2017)... -- The Corporate Whistleblower Center says, "We are urging ... to call us anytime at 866-714-6466 if they possess ... a substantial scheme to overbill Medicare. We are ... of a medical equipment company if their employer ... practice groups with extra generous incentives to use, or ...
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
Breaking Medicine Technology: